Abstract
Introduction SPAK (SPS1-related proline/alanine-rich kinase) is a key regulator of renal tubular salt transport and blood pressure [1] [2] [3] . SPAK is under control of the with-no-K(Lys) (WNK) kinases [1, [4] [5] [6] [7] [8] , which are similarly decisive for renal salt excretion and blood pressure regulation [7, [9] [10] [11] [12] . Mutations within WNK kinases cause Gordon's syndrome, a monogenic disease leading to hypertension and hyperkalaemia [6, 8, 13, 14] . SPAK and the related oxidative stress-responsive kinase 1 (OSR1) kinase modify renal salt excretion and blood pressure at least partially through activation of the NaCl cotransporter (NCC) and the Na + ,K + ,2Cl
-cotransporter (NKCC2) [4, 5, 7, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Inhibition of NCC with thiazides is followed by anticalciuria [26] . Moreover, thiazide sensitive NCC activity is a powerful regulator of bone differentiation and bone mineralisation [27, 28] . Thus, at least in theory, WNK sensitive regulation of SPAK could participate in the regulation of Ca 2+ and phosphate metabolism. As a matter of fact, a WNK4 gene variant has been shown to be associated with osteoporosis [29] . However, nothing is known about a role of SPAK in the regulation of renal tubular transport of Ca 2+ and phosphate. Renal phosphate excretion is under regulation by dietary phosphate intake, acid-base status, parathyroid hormone, 1,25-(OH) 2 vitamin D 3 , FGF23, insulin and insulin-like growth factor IGF1 [30] [31] [32] [33] [34] [35] [36] . Signaling known to regulate renal tubular phosphate transport include protein kinases A and C, ERK1/2, Klotho and the PI3K/PKB/GSK3 kinase cascade [37] [38] [39] [40] [41] [42] [43] [44] .
The present study addressed the putative role of SPAK in the regulation of renal Ca 
Materials and Methods

Animals
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities. Blood was drawn, urine collected or tissue isolated from sex-and agematched 3-8-month-old homozygous SPAK knockin mice (spak tg/tg ) and respective wild type mice (spak wt/wt ), kindly provided by Dario Alessi. As described earlier [1] in the knockin mice the T-loop Thr residue in SPAK (Thr243) was mutated to Ala to prevent activation by WNK isoforms. Mice had free access to control diet (sniff, Soest, Germany) containing 7000 mg/kg phosphorus or to phosphate-depleted diet (Altromin, Lage, Germany) containing 131 mg/kg phosphate and to tap drinking water ad libitum. Where indicated, the mice were treated with hydrochlorothiazide (Sigma Aldrich, Germany), which was first dissolved in DMSO and then in drinking water at the dose of 600 mg/l for 12 days. To obtain serum, mice were anaesthetized with diethylether (Roth, Karlsruhe, Germany) and blood was drawn into capillaries by puncturing the retroorbital plexus.
To determine urinary parameters, the mice were placed individually in metabolic cages (Techniplast, Hohenpeissenberg, Germany) as described previously. They were allowed a 2 day habituation period during which food and water intake, urinary flow rate and phosphate excretion were recorded every day to ascertain that the mice were adapted to the new environment. Subsequently, 24 h collection of urine was performed for three consecutive days in order to obtain the urinary parameters. This procedure was repeated under low-phosphate diet. To assure quantitative urine collection, metabolic cages were siliconized, and urine was collected under water-saturated oil.
The phosphate concentration was determined colorimetrically utilizing a commercial diagnostic kit (Roche Diagnostics, Mannheim, Germany). ELISA kits were employed for determination of the serum intact parathormone concentration (Immutopics, San Clemante, USA), of 1,25(OH) 2 
Bone density
For the analysis of bone density, animals were sacrificed and legs were amputated and fixated in PFA (paraformaldehyde). The samples were scanned with a high resolution X-ray computed tomography (Inveon SPECT/CT) scanner (Siemens Preclinical Solutions, Knoxville, TN, USA) using a field of view of 3.6 x 3.6 x 3,6 cm³. The X-ray tube parameters were set at 80 kVp and 500 µA. The images were acquired with 400 angular projections (exposure time 1000 ms per projection) over 200 degree and binned with a factor of two, yielding a reconstructed pixel size of ~35 µm. The total scan time was 12 minutes. Reconstructed CT images were analyzed with the Inveon Research Workplace software (Siemens Preclinical Solutions, USA), by drawing a standard-sized container around the femur and applying a region growth routine to segment the trabecular bone structure. For all samples, the same upper and lower density threshold was applied and the relative numbers of trabecular bone density compared.
SPAK transcripts in UMR106 cells
Rat osteosarcoma UMR106 cells (10 6 ) were cultured in Dulbecco's MEM medium, supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 50 units/ml penicillin, and 50 µg/ml streptomycin, at 5% CO 2 , and 37°C for 2 days. Cells were lysed, total RNA isolated (Mini kit, Qiagen, Hilden, Germany) and 1 µg transcribed into cDNA using reverse transcriptase (Roche Diagnostics GmbH, Roche Applied Science, Mannheim Germany). Aliquots of cDNA, corresponding to equal amounts of RNA, were used for quantification of mRNA. Specific primers for rat used were:
Sense primer: AAGTCATGGAACAGGTGAGAGGC Antisense primer: TTCAGTCTTATGAAGGTGACCGC The mRNA was subjected to RT-PCR analysis using the light cycler system (Roche Diagnostics GmbH, Roche Applied Science, Mannheim Germany). The reaction mixture of 20 µl contained cDNA, 10 mM MgCl 2 , 0.5 µM of each primer, and 1 µl Master Syber Green I mix (LightCycler TM FastStart Master Syber Green, Roche). The transcript level of the housekeeping gene GAPDH of the sample was taken as reference using a commercial primer kit (Search LC, Heidelberg, Germany). Amplification of the target DNA was performed during 35 cycles, each of 10 s at 95°C, 10 s at 68°C and 16 s at 72°C. The product size was analysed on 1.5% agarose gel.
Statistics
Data are provided as means ± SEM, n represents the number of independent experiments. All data were tested for significance using unpaired Student's t-test or ANOVA, as appropriate. Only results with p < 0.05 were considered statistically significant.
Results
In order to elucidate, whether phosphate metabolism is sensitive to WNK dependent regulation of SPAK, experiments were performed in SPAK knockin mice (spak tg/tg ), which were carrying a WNK-insensitive T243A SPAK mutant. The animals were compared to respective wild type mice (spak wt/wt ). Urinary phosphate excretion was significantly higher in spak tg/tg mice than in spak wt/wt mice (Fig. 1 ). As shown in Fig. 1 As phosphaturia could have resulted from altered hormone levels, the serum concentration of parathyroid hormone (PTH), calcitriol (1,25(OH) 2 D 3 ), and fibroblast growth factor 23 (FGF23) were determined. As shown in Fig. 3 , the serum concentrations of PTH (Fig. 3A) and of 1,25(OH) 2 D 3 ( Fig. 3B) were similar in spak tg/tg mice and in spak wt/wt mice. The serum FGF23 concentration was, however, significantly higher in spak tg/tg mice than in spak wt/wt mice (Fig. 3C) . (Fig. 3A-C) . As SPAK stimulates the thiazide sensitive NaCl cotransporter, additional experiments were performed to elucidate whether thiazide treatment similarly influences FGF23 serum levels. As illustrated in Fig. 4 , hydrochlorothiazide treatment was followed by a significant increase of FGF23 serum levels, which was paralleled by phosphaturia and hypophosphatemia, thus mimicking the phenotype of spak tg/tg mice. Further experiments were performed to elucidate whether the enhanced FGF23 release was paralleled by altered bone density. As shown in Fig. 5 , bone density was significantly higher in spak tg/tg mice than in spak wt/wt mice. In order to test, whether Spak is expressed in osteoblasts, mRNA encoding Spak was determined by RT-PCR. As illustrated in Fig. 6 , the SPAK transcript was indeed detected in rat osteosarcoma UMR106 cells.
Discussion
The present observations reveal a completely novel function of WNK/SPAK signaling, i.e. its participation in the regulation of calcium phosphate metabolism and bone density. According to the present observations, WNK insensitivity of SPAK decreases urinary Ca 2+ excretion, increases bone density, upregulates FGF23 release, and increases urinary phosphate excretion.
The phosphaturia in spak tg/tg mice was paralleled by hypophosphatemia and was thus not due to increased serum phosphate concentration. Conversely, the urinary phosphate loss presumably accounts for the hypophosphatemia of the spak tg/tg mice. In theory, the phosphaturia of spak tg/tg could have resulted from increased serum levels of PTH, a powerful hormone fostering internalization and degradation of NaPiIIa [34, 38] , the most important renal tubular phosphate transporter [45] [46] [47] . Thus, PTH leads to phosphaturia and hypophosphatemia [34, 38] . The PTH serum concentration tended, however, to be rather decreased in spak tg/tg mice. Thus, increased PTH plasma concentrations do presumably not [52] . The 1α-hydroxylase is further stimulated by PTH [53] . The upregulation of 1,25(OH) 2 D 3 during dietary phosphate depletion presumably contributed to the decrease of urinary phosphate output.
The decrease of renal tubular phosphate reabsorption may well have resulted from increased release of FGF23, which is known to decrease renal tubular phosphate transport and plasma phosphate concentration [54] . FGF23 formation is stimulated by 1,25(OH) 2 D 3 and FGF23 in turn decreases the formation of 1,25(OH)2D 3 [55, 56] . FGF23 formation is further stimulated by PTH, increased phosphate intake and hyperphosphatemia [57] [58] [59] . Accordingly, phosphate deficient diet decreased serum FGF23 levels. However, the enhanced FGF23 serum level of spak tg/tg mice cannot be explained by PTH or hypophosphatemia. In theory, SPAK may influence FGF23 release from osteoblasts indirectly, by stimulating the NaCl cotransporter NCC. Along those lines, hydrochlorothiazide indeed increased FGF23 release, an effect paralleled by phosphaturia and hypophosphatemia. Thus, inhibition of NCC mimics the phenotype of spak tg/tg mice. Along those lines, NCC activity plays a pivotal role for bone differentiation and bone mineralisation [27] . The present observations do, however, not allow discriminating, whether the effect of hydrochlorothiazide on FGF23 plasma concentration was secondary to inhibition of NCC in kidney or in bone.
The phosphaturia of spak tg/tg mice is paralleled by anticalciuria, which may again be an indirect effect of impaired NaCl cotransporter activity. In view of the present observations it is tempting to speculate that the phosphaturia is the result of the following sequence of events: Lack of renal tubular SPAK activity decreases the activity of the NaCl cotransporter in early distal tubule. The volume depletion triggers a compensatory increase of NaCl reabsorption in proximal renal tubules and Henle´s Loop. The enhanced proximal tubular and loop Na + reabsorption is paralleled by a similar increase of Ca 2+ reabsorption resulting in anticalciuria. The renal Ca 2+ retention enhances bone mineralization, which triggers FGF23 release. The enhanced FGF23 levels cause phosphaturia. Along those lines, inhibition of the NaCl cotransporter with hydrochlorothiazide similarly leads to anticalciuria, an effect again at least partially explained by compensatory increase of proximal tubular Na + reabsorption with parallel increase of renal tubular Ca 2+ reabsorption [26] . The rather constant plasma concentration of Ca 2+ does not support the assumption that Ca 2+ retention drives enhanced bone mineralisation in spak tg/tg mice. It should be kept in mind, though, that it is the free ionized Ca 2+ rather than total Ca 2+ , which is relevant for bone mineralisation. The hypophosphatemia decreases complexation of Ca 2+ by phosphate and the free Ca 2+ concentration may, at least in theory, be indeed (slightly) higher in spak tg/tg mice and spak wt/wt mice.
Conclusion
WNK/SPAK signaling participates in the regulation of FGF23 release as well as renal tubular Ca 2+ and phosphate transport. WNK resistance of SPAK activity leads to increased FGF23 release, anticalciuria, phosphaturia, hypophosphatemia and enhanced bone density. The present observations thus disclose a novel, powerful mechanism contributing to the regulation of mineral metabolism and a novel functional role of WNK/SPAK signaling.
